+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Plague Drug"

Plague - Pipeline Insight, 2024 - Product Thumbnail Image

Plague - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Plague - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Plague - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Plague - Epidemiology Forecast to 2032 - Product Thumbnail Image

Plague - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Plague - Pipeline Review, H2 2020 - Product Thumbnail Image

Plague - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 66 Pages
  • Global
From
Plague (Infectious Disease) - Drugs in Development, 2021 - Product Thumbnail Image

Plague (Infectious Disease) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The Plague Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs to treat and prevent the plague. Plague is a bacterial infection caused by the Yersinia pestis bacteria, which is spread through flea bites and contact with infected animals. Plague drugs are used to treat the infection and prevent its spread. These drugs are typically antibiotics, such as streptomycin, gentamicin, and doxycycline. The Plague Drug market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and Johnson & Johnson. These companies are constantly researching and developing new drugs to treat and prevent plague, as well as to improve existing treatments. Show Less Read more